RecruitingNCT07508930

Russian Extreme Hypertriglyceridemia Registry

Russian Extreme Hypertriglyceridemia Registry (REGGI)

Sponsor

Russian Cardiology Research and Production Center

Enrollment

500 participants

Start Date

Nov 20, 2025

Study Type

OBSERVATIONAL

Conditions

Hypertriglyceridemia

Summary

The REGGI registry is a prospective, multicenter observational registry in Russia designed to collect data on patients with extreme hypertriglyceridemia (triglyceride levels ≥10 mmol/L). The registry aims to describe the clinical, demographic, and molecular-genetic characteristics of patients, as well as current diagnostic approaches and treatment patterns in real-world practice. The collected data may inform future research and support improvements in patient care.

Eligibility

Inclusion Criteria3

Patients with extreme hypertriglyceridemia (triglyceride levels ≥10 mmol/L), confirmed by at least two independent measurements.
Written informed consent from the patient or legal guardian.
No age restrictions.

Exclusion Criteria2

Patients whose extreme hypertriglyceridemia is caused by alcohol abuse, uncontrolled diabetes, or other medical conditions, unless extreme hypertriglyceridemia is confirmed after controlling the underlying condition.
Lack of informed consent.

Print for Your Doctor

Interested in this trial?

Get notified about updates and connect with the research team.